Nanologica approves rights issue of about SEK 110.5 million

what happened

The board of directors of Sweden's Nanologica AB has approved a new issue of units worth about SEK 110.5 million, offered first to existing shareholders. TradingView reported the decision based on the company's press release, and Reuters carried a shorter version of the same announcement.

The subscription price is SEK 1.68 per unit, and each unit contains ten new shares. If the offer is oversubscribed, the board intends to use an option for up to SEK 10 million more. Subscription is expected to run from 3 to 17 November 2026. Subscription and guarantee commitments cover about 77.6% of the issue.

The raise is tied to a strategy review that puts more emphasis on commercial growth in North America and Europe. Mark Quick has been named the group's new CEO, while Andreas Bhagwani will lead the purification and separation business. Axel Elner will join as group CFO in mid-November.

why it matters

For the market, the key point is that the company is raising capital during a restructuring and as it works toward profitability. Shareholders who do not take part will see their stake diluted. Guarantees from the principal owner, the chairman and partner Sterling Pharma Solutions, including a set-off of receivables, reduce the risk of an incomplete placement. The deal is small, so its impact stays largely within the company's own shares.

tags

instruments